- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07640464
Diaphragmatic Effects of Combined Infraclavicular Brachial Plexus Block and Suprascapular Nerve Block (ICB-SNB)
Evaluation of the Effects of Combined Infraclavicular Brachial Plexus Block and Suprascapular Nerve Block on the Diaphragm in Arthroscopic Shoulder Surgery
Studienübersicht
Status
Detaillierte Beschreibung
This prospective observational study was conducted to evaluate the effects of combined infraclavicular brachial plexus block and anterior suprascapular nerve block on diaphragmatic excursion in patients undergoing elective arthroscopic shoulder surgery.
Patients scheduled for arthroscopic shoulder surgery under regional anesthesia were enrolled in the study. Prior to block administration, baseline diaphragmatic excursion was assessed using ultrasonography during both normal and deep breathing. Each measurement was repeated three times, and the mean value was recorded. The same measurements were repeated 30 minutes after completion of the block procedures using an identical protocol.
The percentage change in diaphragmatic excursion between baseline and post-block measurements was calculated for both normal and deep breathing. Hemidiaphragmatic paralysis was categorized according to the degree of reduction in diaphragmatic excursion as absent (≤25% reduction), partial (25.1-74.9% reduction), or complete (≥75% reduction).
All nerve blocks were performed under ultrasound guidance by anesthesiologists experienced in regional anesthesia techniques. The infraclavicular brachial plexus block was performed using 15 mL of 0.5% bupivacaine deposited around the posterior cord and 8 mL of 0.5% bupivacaine around the lateral cord. The anterior suprascapular nerve block was performed with 7 mL of 0.5% bupivacaine. In addition, arthroscopic portal sites were infiltrated with 10 mL of 0.2% bupivacaine to provide supplementary analgesia.
All patients received intravenous midazolam (2 mg) and paracetamol (1 g) during the intraoperative period. Additional analgesic or sedative medication was administered when required according to clinical conditions and surgical needs. Block performance time, requirement for supplemental analgesia or sedation, and any block-related adverse events were recorded.
The primary outcome measure was the change in diaphragmatic excursion measured by ultrasonography 30 minutes after block administration. Secondary outcome measures included the incidence and severity of hemidiaphragmatic paralysis, block performance time, duration of postoperative analgesia, need for additional intraoperative analgesia or sedation, time to first analgesic requirement, patient and surgeon satisfaction, block-related complications, and conversion to general anesthesia.
The study was designed to investigate whether the combination of infraclavicular brachial plexus block and anterior suprascapular nerve block could provide effective anesthesia and analgesia for arthroscopic shoulder surgery while minimizing impairment of diaphragmatic function and reducing the incidence of clinically significant hemidiaphragmatic paralysis.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Ankara
-
Ankara, Ankara, Türkei (türkiye), 06500
- Gazi University Faculty of Medicine Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Patients aged 18-80 years.
- ASA physical status I-III.
- Scheduled for elective arthroscopic shoulder surgery.
- Ability to provide written informed consent
Exclusion Criteria:
- Refusal to undergo peripheral nerve block.
- Pre-existing peripheral neuropathy.
- Known pulmonary, hepatic, or renal disease.
- Allergy to local anesthetics.
- Infection at the block site.
- Pre-existing neurological deficit.
- Body mass index (BMI) > 40 kg/m².
- Coagulopathy.
- Sepsis.
Previous surgery at the planned block site.
- Major psychiatric disorders.
- Inability to complete diaphragmatic ultrasonographic assessment.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Patients Undergoing Arthroscopic Shoulder Surgery
Patients undergoing arthroscopic shoulder surgery who received a combined infraclavicular brachial plexus block and anterior suprascapular nerve block.
Diaphragmatic excursion was evaluated using ultrasonography before and after block administration.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Diaphragmatic Excursion at 30 Minutes After Block Administration
Zeitfenster: 30 minutes after block administration
|
Diaphragmatic excursion measured by ultrasonography during normal and deep breathing before block administration and 30 minutes after block administration.
The percentage change from baseline was calculated.
|
30 minutes after block administration
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Incidence of Hemidiaphragmatic Paralysis
Zeitfenster: 30 minutes after block administration
|
Presence of hemidiaphragmatic paralysis determined by ultrasonographic assessment of diaphragmatic excursion.
|
30 minutes after block administration
|
|
Degree of Hemidiaphragmatic Paralysis
Zeitfenster: 30 minutes after block administration
|
Hemidiaphragmatic paralysis classified as absent (≤25% reduction), partial (25.1-74.9%
reduction), or complete (≥75% reduction)
|
30 minutes after block administration
|
|
Block Performance Time
Zeitfenster: From needle insertion to completion of the block procedure
|
Time required to complete the combined infraclavicular brachial plexus block and anterior suprascapular nerve block.
|
From needle insertion to completion of the block procedure
|
|
Additional Intraoperative Analgesia Requirement
Zeitfenster: From surgical incision to the end of surgery
|
Requirement for supplemental analgesic medication during surgery.
|
From surgical incision to the end of surgery
|
|
Time to First Analgesic Requirement
Zeitfenster: Up to 24 hours after surgery
|
Time from completion of the block procedure to the first postoperative analgesic request.
|
Up to 24 hours after surgery
|
|
Block-Related Complications
Zeitfenster: From block administration until 24 hours after surgery
|
Incidence of block-related adverse events including Horner syndrome, hoarseness, nausea/vomiting, and hemodynamic complications.
|
From block administration until 24 hours after surgery
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: IRFAN GUNGOR, MD, Gazi University Faculty of Medicine
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 2024-GUTF-028
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Arthroskopische Schulterchirurgie
-
Cairo UniversityNoch keine RekrutierungEnhanced Recovery After Surgery (ERAS)-ProtokollÄgypten
-
West China HospitalRekrutierungOn-Pump Valve Surgery oder CABGChina
-
National Taiwan University HospitalAnmeldung auf EinladungPädiatrie | Lungenchirurgie | Enhanced Recovery After Surgery, ERASTaiwan
-
Gazi UniversityAbgeschlossenSchwangere Frau | Enhanced Recovery After Surgery (ERAS)-ProtokollTruthahn
-
Bursa City HospitalNoch keine RekrutierungKinderchirurgie | Präoperatives Fasten | Enhanced Recovery After Surgery (ERAS)-ProtokollTürkei (türkiye)
-
Karolinska InstitutetErsta Hospital, SwedenAbgeschlossenLoopileostomie | Fast-Track-Programm (Enhanced Recovery After Surgery (ERAS))Schweden
-
Kulsoom International HospitalRekrutierungErector-Spinae-Block | Opioid | Enhanced Recovery After Surgery (ERAS)-ProtokollPakistan
-
Istanbul University - CerrahpasaNoch keine RekrutierungPädiatrische Anästhesie | Pädiatrische postoperative Genesung | Pädiatrisches Enhanced Recovery After SurgeryTürkei (türkiye)
-
Universitair Ziekenhuis BrusselNoch keine RekrutierungFailed Back Surgery Syndrom | Anhaltendes Wirbelsäulenschmerzsyndrom Typ 2 | Failed Neck Surgery-SyndromBelgien
-
Brai²nRekrutierungNeurophysiologische Empfindlichkeit gegenüber Rückenmarksstimulation | Failed Back Surgery Syndrome (FBSS) | Persistent Spinal Pain Syndrome Typ 2 (PSPS-T) Untere WirbelsäuleBelgien